In a study of therapeutics targeting cancers, mTOR activation triggered CREB1 phosphorylation and accumulation, and inhibiting CREB1 led to a decrease in ATG7, which is a key factor in autophagy regulation [79]. Here, ATG7 is linked to cancer.